Kokilaben Hospital launches Hereditary Cancer Clinic to strengthen personalised cancer care in India

Hereditary Cancer Clinic unveiled at International Symposium on Precision Oncology and Personalised Medicine

Kokilaben Dhirubhai Ambani Hospital has announced the launch of Hereditary Cancer Clinic at the International Symposium on Precision Oncology and Personalised Medicine organised by Kokilaben Hospital. This clinic aims to provide personalised cancer care to patients across India. It follows the pioneering efforts of Kokilaben Hospital in introducing personalised targeted cancer treatment, harnessing the power of precision medicine to deliver innovative therapies that effectively address individual patient needs.

The symposium, which brought together leading oncologists, researchers, and medical professionals from around the world had panel discussions with enlightening insights on recent advancements and innovative treatment strategies in cancer care and the future of precision oncology.

Precision oncology with personalised cancer treatment involves leveraging cutting-edge technology and in-depth genetic insights to tailor treatment plans to each patient’s unique genetic makeup and cancer characteristics. Kokilaben Hospital has been at the forefront of this approach, providing comprehensive care that encompasses every aspect of the patient’s cancer journey. The Hereditary Cancer Clinic is an integral part of this process, offering extensive genetic counselling and testing services to identify and manage genetic risk factors associated with various cancers.

The symposium also included a felicitation ceremony with Tina Anil Ambani, Chairperson, Kokilaben Hospital honoring eminent doctors and achievers in the field of oncology from across India and the world. She said, “Cancer care is an overarching priority for Kokilaben Hospital, which has always been ahead of the curve in terms of technology and talent. We recognise that precision oncology and personalised medicine is the new frontier in cancer care and are delighted to host this symposium, which provides a wealth of information, a platform for deliberation, an opportunity for interaction and a forum to felicitate excellence. On this occasion, I am also delighted to announce that we are continuing to focus on precision oncology and personalised medicine, by launching a hereditary cancer clinic, which will help predict familial risk for cancer and take measures to control the same. This is one more significant step in our mission to ‘Contain, Combat and Conquer Cancer’.”

Dr Santosh Shetty, CEO and Executive Director, Kokilaben Dhirubhai Ambani Hospital said, “Kokilaben Hospital has remained ahead of the curve and in line with the best global practices in cancer care. Our dedication to advancing personalized cancer care is evident in our commitment to investing in cutting-edge technology and research. The Hereditary Cancer Clinic demonstrates our relentless pursuit of excellence in Precision Oncology. With a multidisciplinary team of skilled experts, cutting-edge facilities, and the latest technologies, the addition of the new clinic is a testament to the largest commitment by any single institute in cancer, and is expected to make a significant difference in cancer outcomes.”

Kokilaben Hospital with its active cancer care centres across Maharashtra in Akola, Gondia, and Solapur, the Institute has a skilled team of more than 45 consultants and 225 members in the oncology team. The team has administered over 175000 chemotherapies, 6 lakh radiation cycles, and performed 63000 surgeries.